Regression of ovarian cancer xenografts by depleting or inhibiting RLIP.
Ramisetty SK, Garg P, Mohanty A, Mirzapoiazova T, Yue E, Wang E, Horne D, Awasthi S, Kulkarni P, Salgia R, Singhal SS.
Ramisetty SK, et al. Among authors: garg p.
Biochem Pharmacol. 2023 Nov;217:115847. doi: 10.1016/j.bcp.2023.115847. Epub 2023 Oct 5.
Biochem Pharmacol. 2023.
PMID: 37804871